Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes

导出原文传递

翻译打印收藏纠错

作者： Vanita R. Aroda ^[1] ; Umut Erhan ^[2] ; Peter Jelnes ^[3] ; Juris J. Meier ^[4] ; Morten Tind Abildlund ^[5] ; Richard Pratley ^[6] ; Tina Vilsb?ll ; Mansoor Husain

作者单位： Brigham and Women's Hospital, Harvard Medical School ^[1] Novo Nordisk A/S ^[2] Department of Internal Medicine, Gastroenterology, Hepatology and Diabetology,Augusta Clinic ^[3] AdventHealth Translational Research Institute ^[4] Clinical Research, Steno Diabetes Center Copenhagen ^[5] Ted Rogers Centre for Heart Research, Department of Medicine,University of Toronto ^[6]

关键词 antidiabetic drug GLP‐1 phase III study randomized trial type 2 diabetes

发布时间 2023-08-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交